» Articles » PMID: 10722447

High Prevalence of Abscesses and Cellulitis Among Community-recruited Injection Drug Users in San Francisco

Overview
Journal Clin Infect Dis
Date 2000 Mar 18
PMID 10722447
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of and risk factors for abscesses and cellulitis were investigated among a community sample of injection drug users (IDUs). Participants were interviewed, and those with symptoms were examined. Of 169 IDUs, 54 (32%) had abscesses (n=35), cellulitis (n=5), or both (n=14); 27% had lanced their own abscesses; and 16% had self-treated with antibiotics they purchased on the street. IDUs who skin-popped (injected subcutaneously or intramuscularly) were more likely to have an abscess or cellulitis than those who had injected only intravenously (odds ratio, 4.9; 95% confidence interval, 2.2-11). The likelihood of abscesses and cellulitis increased with frequency of skin-popping and decreased with increasing duration of injection drug use. Abscesses are extremely prevalent among IDUs in San Francisco. Skin-popping is a major risk factor, and self-treatment is common.

Citing Articles

Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021.

Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F Drug Alcohol Depend. 2024; 263:111419.

PMID: 39216201 PMC: 11684856. DOI: 10.1016/j.drugalcdep.2024.111419.


Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs: a longitudinal study.

Jorgensen J, Dahlman D, Alanko Blome M, Janson H, Riesbeck K, Nilsson A Sci Rep. 2024; 14(1):12919.

PMID: 38839902 PMC: 11153592. DOI: 10.1038/s41598-024-63574-y.


Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk....

Young A, Havens J, Cooper H, Fallin-Bennett A, Fanucchi L, Freeman P BMJ Open. 2024; 14(3):e083983.

PMID: 38431295 PMC: 10910671. DOI: 10.1136/bmjopen-2024-083983.


Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.

Marks L, Durkin M, Ayres K, Ellis M Harm Reduct J. 2024; 21(1):16.

PMID: 38243269 PMC: 10799462. DOI: 10.1186/s12954-024-00939-6.


Mucocutaneous Manifestations of Recreational Drug Use.

Alexander-Savino C, Mirowski G, Culton D Am J Clin Dermatol. 2024; 25(2):281-297.

PMID: 38217568 DOI: 10.1007/s40257-023-00835-y.